Virtualizing the p-ANAPL library: A step towards drug discovery from african medicinal plants

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Ntie Kang, Fidele ^a   Onguéné, Pascal Amoa ^b   Fotso, Ghislain W ^c   Andrae Marobela, Kerstin ^d   Bezabih, Merhatibeb ^d   Ndom, Jean Claude ^b   Ngadjui, Bonaventure T ^c   Ogundaini, Abiodun O ^e   Abegaz, Berhanu M ^f   Meváa, Luc Mbaze ^b  

^a UNIVERSITY OF BUEA   (Cameroon)

^b UNIVERSITY OF DOUALA   (Cameroon)

^c UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^d UNIVERSITY OF BOTSWANA   (Botswana)

^e OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

^f Kenya National Academy of Sciences   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYLONCHOCARPIN; BARTERICIN A; BROUSSOFLAVONOL B; CAFFEINE; CANNABIDIOL; CHRYSOPHANIC ACID; DINKLAGIN B; DORSMANIN C; ELLAGIC ACID; EMODIN; ESCULETIN; FLAVONOID; GABOROQUINONE A; GABOROQUINONE B; JULOCROTINE; KANZONOL B; KNIPHOLONE; KNIPHOLONE ANTHRONE; MANDELIC ACID; NATURAL PRODUCT; PARA COUMARIC ACID; PHYSCION; PIPERINE; PROROPENSIN; QUERCETIN; QUERCITRIN; SHIKIMIC ACID; STIPULIN; UMBELLIFERONE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AFRICA; ARTICLE; CHEMICAL COMPOSITION; COMPUTER MODEL; DRUG SCREENING; DRUG STRUCTURE; MEDICINAL PLANT; MOLECULAR LIBRARY; NONHUMAN; PAN AFRICAN NATURAL PRODUCTS LIBRARY;

AFRICA; BIOLOGICAL PRODUCTS; DRUG DISCOVERY; HYDROGEN BONDING; PLANTS, MEDICINAL; SMALL MOLECULE LIBRARIES; USER-COMPUTER INTERFACE;

EID: 84897140996     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090655     Document Type: Article

References (99)

1. Vasisht K, Kumar V (2002) Trade and Production of Herbal Medicines and Natural Health Products. ICS-UNIDO, Trieste, pp 3.
2. Vasisht K, Kumar V (2004) Compendium of Medidincal and aromatic plants. Volume 1: Africa. ICS-UNIDO, Trieste, pp 23-56.
3. Harvey AL (2008) Natural products in drug discovery. Drug Discov Today 13: 894-901.
4. Newman DJ (2008) Natural products as leads to potential drugs: an old process or the new hope for drug discovery? J Med Chem 51: 2589-2599.
5. Efange SMN (2002) Natural products: a continuing source of inspiration for the medicinal chemist. In M.M. Iwu & J.C. Wootton (Eds.), Advances in Phytomedicine, Vol. 1, Ethnomedicine and Drug Discovery (61-69). Amsterdam, The Netherlands: Elsevier Science.
6. Hostettmann K, Marston A, Ndjoko K, Wolfender JL (2000) The potential of African plants as a source of drugs. Curr Org Chem 4: 973-1010.
7. Chibale K, Davies-Coleman M, Masimirembwa C (2012). Drug discovery in Africa: impacts of genomics, natural products, traditional medicines, insights into medicinal chemistry, and technology platforms in pursuit of new drugs. Springer.
8. Titanji VPK, Zofou D, Ngemenya M (2008) The antimalarial potential of medicinal plants used for the treatment of malaria in Cameroonian folk medicine. Afr J Trad CAM 5(3):302-321.
9. Schwikkard S, van Heerden FR (2002) Antimalarial activity of plant metabolites. Nat Prod Rep 19: 675-692. (Pubitemid 36029226)
10. Kuete V, Efferth T (2010) Cameroonian medicinal plants: pharmacology and derived natural products. Front Pharmacol 1: 123.
11. Ntie-Kang F, Lifongo LL, Mbaze LM, Ekwelle N, Owono LCO, et al. (2013) Cameroonian medicinal plants: a bioactivity versus ethnobotanical survey and chemotaxonomic classification. BMC Complement Altern Med 13(1): 147.
12. Magadula JJ, Erasto P (2009) Bioactive natural products derived from the East African flora. Nat Prod Rep 26: 1535-1554.
13. OnguénéPA, Ntie-Kang F, Lifongo LL, Ndom JC, Sippl W, et al. (2013) The potential of anti-malarial compounds derived from African medicinal plants. Part I: A pharmacological evaluation of alkaloids and terpenoids. Malar J 2013, 12: 449.
14. Ntie-Kang F, Onguéné PA, Lifongo LL, Ndom JC, Sippl W, et al. (2013) The potential of anti-malarial compounds derived from African medicinal plants. Part II: A pharmacological evaluation of non alkaloids and non terpenoids. Malar J submitted.
15. Kuete V (2010) Potential of Cameroonian plants and derived products against microbial infections: a review. Planta Med 76: 1479-1491.
16. Zofou D, Ntie-Kang F, Sippl W, Efange SMN (2013) Bioactive natural products derived from the Central African flora against neglected tropical diseases and HIV. Nat Prod Rep 30:1098-1120.
17. Koehn FE, Carter GT (2005) The evolving role of natural products in drug discovery. Nat Rev Drug Discov 4: 206-220. (Pubitemid 40372555)
18. Li JWH, Vederas JC (2009) Drug discovery and natural products: end of an era or an endless frontier? Science 325: 161-165.
19. Lam KS (2007) New aspects of natural products in drug discovery. Trends Microbiol 15: 279-289.
20. Pan L, Chai HB, Kinghorn AD (2013) Discovery of new anticancer agents from higher plants. Front. Biosci. (Schol Ed.) 4: 142-156.
21. Quinn RJ, Carroll AR, Pham MB, Baron P, Palframan ME, et al. (2008) J Nat Prod 71: 464-468.
22. Irwin JJ, Shoichet BK (2005) ZINC - A free database of commercially available compounds for virtual screening. J Chem Inf Model 45(1): 177-182. (Pubitemid 40736970)
23. Irwin JJ, Sterling T, Mysinger MM, Bolstad ES, Coleman RG (2012) ZINC: A free tool to discover chemistry for biology. J Chem Inf Model 52: 1757-1768.
24. Chemical Computing Group Inc: Molecular Operating Environment Software. Montreal; 2010.
25. Halgren TA (1996) Merck molecular forcefield. J Comput Chem 17:490-641.
26. Dobson CM (2004) Chemical space and biology. Nature 432(7019): 824-828.
27. Gu J, Gui Y, Yuan G, Lu HZ, Xu X (2013) Use of natural products as chemical library for drug discovery and network pharmacology. PLOS ONE 8(4): e62839.
28. Feher M, Schmidt JM (2003) Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry. J Chem Inf Comput Sci 43:218-227.
29. Andrae-Marobela K, Fotso WG, Okatch H, Majinda RRT (2013) Polyphenols: A diverse class of multi-target anti HIV-agents. Current Drug Metabolism 14: 392-413.
30. Abegaz BM, Ngadjui BT, Dongo E, Bezabih MT (2000) Chemistry of the genus Dorstenia. Current Contents in Organic Chemistry 4: 1079-1090.
31. Abegaz BM, Ngadjui BT, Dongo E, Ngameni B, Nindi N, Bezabih MT (2002) Chalcones and other constituents of Dorstenia proropens and D. zenkeri. Phytochemistry 59(8): 877.
32. Silayo A, Ngadjui BT, Abegaz BM (1999) Homoisoflavonoids and stilbenes from the bulbs of Scilla nervosa. Phytochemistry, 52: 947-955.
33. Abegaz BM, Bezabih M, Msuta T, Brun R, Menche D, et al. (2002) Gaboroquinones A and B and 4′-O-demethylknipholone-4′-O-beta-D- glucopyranoside, phenylanthraquinones from the roots of Bulbine frutescens. J Nat Prod 65(8): 1117-1121. (Pubitemid 34976488)
34. Mutanyatta J, Bezabih M, Abegaz BM, Dreyer M, Brun R, et al. (2005) The first 6′-O-sulfated phenylanthraquinones: Isolation from Bulbine frutescens, structural elucidation, enantiomeric purity, and partial synthesis. Tetrahedron 61: 8475-8484. (Pubitemid 41058691)
35. Guo MX, Wang ML, Deng H, Zhang XT, Wang ZY (2013) A novel anticancer agent Broussoflavonol B downregulates estrogen receptor (ER)-alpha36 expression and inhibits growth of ER-negative breast cancer MDA-MB-231 cells. Eur J Pharmacol 714: 56-64.
36. Guimarães LR, Rodrigues AP, Marinho PS, Muller AH, Guilhon GM, et al. (2010) Activity of the julocrotine, a glutarimide alkaloide from Croton pullei var. glabrior, on Leishmania (L.) amazonensis. Parasitol Res 107(5): 1075-1081.
37. Mbaveng AT, Kuete V, Ngameni B, Beng VP, Ngadjui BT, et al. (2012) Antimicrobial activities of the methanol extract and compounds from the twigs of Dorstenia mannii (Moraceae). BMC Complement Altern Med 12: 83.
38. Yongye AB, Waddell J, Medicna-Franco JL (2012) Molecular scaffold analyisis of natural product databases in the public domain. Chem Biol Drug Des 80(5): 717-724.
39. Fullbeck M, Michalsky E, Dunkel M, Preissner R (2006) Natural products: sources and databases. Nat Prod Rep 23:347-356. (Pubitemid 43847137)
40. Dunkel M, Fullbeck M, Neumann S, Preissner R (2006) SuperNatural: a searchable database of available natural compounds. Nucleic Acids Res 34:D678-D683.
41. Ntie-Kang F, Mbah JA, Mbaze LM, Lifongo LL, Scharfe M, et al. (2013) CamMedNP: Building the Cameroonian 3D structural natural products database for virtual screening. BMC Complement Altern Med 13: 88.
42. Ntie-Kang F, Onguéné PA, Scharfe M, Owono LCO, Megnassan E, et al. (2014) ConMedNP: A natural product library from Central African medicinal plants for drug discovery. RSC Adv 2014, 4: 409-419.
43. Ntie-Kang F, Zofou D, Babiaka SB, Meudom R, Scharfe M, et al. (2013) AfroDb: A select highly potent and diverse natural product library from African medicinal plants. PLOS ONE 8: e78085.
44. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Delivery Rev 46:3-26. (Pubitemid 33653411)
45. Lipinski CA (2000) Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods 44: 253-249.
46. Teague SJ, Davis AM, Leeson PD, Opea TI (1999) The design of leadlike combinatorial libraries. Angew Chem, Int Ed 38: 3743-3748. (Pubitemid 30022004)
47. Hann MM, Oprea TI (2004) Pursuing the leadlikeness concept in pharmaceutical research. Curr Opin Chem Biol 8: 255-263 (Pubitemid 38759400)
48. Oprea TI (2002) Current trends in lead discovery: are we looking for the appropriate properties J Comput-Aided Mol Des 16: 325-334.
49. Schneider G (2002) Trends in virtual computational library design. Curr Med Chem 9: 2095-2102.
50. Verdonk ML, Cole JC, Hartshorn ML, Murray CW, Taylor RD (2003) Improved protein-ligand docking using GOLD. Proteins 52: 609-623 (Pubitemid 37034158)
51. Khanna V, Ranganathan S (2011) Structural diversity of biologically interesting datasets: a scaffold analysis approach. J Cheminform 3: 30
52. Palomo JM, Fernandez-Lorente G, Mateo C, Ortiz C, Fernandez-Lafuente R, et al. (2002) Modulation of the enantioselectivity of lipases via controlled immobilization and medium engineering: hydrolytic resolution of mandelic acid esters. Enzyme and Microbial Technology 31: 775-783. (Pubitemid 35279816)
53. Zofou D, Tematio EL, Ntie-Kang F, Tene M, Ngemenya MN, et al. (2013) New antimalarial hits from Dacryodes edulis (Burseraceae) - Part I: isolation, in vitro activity, in silico "drug-likeness" and pharmacokinetic profiles. PLOS ONE 8(11): e79544.
54. Pecere T, Gazzola MV, Mucignat C, Parolin C, Dalla F, et al. (2000) Aloe-emodin is a new type of anticancer agent with selective activity against neuroectodermal tumors. Cancer Res 60: 2800-2804. (Pubitemid 30395795)
55. Kuo PL, Lin TC, Lin CC (2002) The antiproliferative activity of aloe-emodin is through p53-dependent and p21-dependent apoptotic pathway in human hepatoma cell lines. Life Sci 71: 1879-1892.
56. Cárdenas C, Quesada AR, Medina MA (2006) Evaluation of the anti-angiogenic effect of aloe-emodin. Cell Mol Life Sci 63: 3083-3089. (Pubitemid 46072310)
57. Chen YY, Chiang SY, Lin JG, Ma YS, Liao CL, et al. (2010) Emodin, aloe-emodin and rhein inhibit migration and invasion in human tongue cancer SCC-4 cells through the inhibition of gene expression of matrix metalloproteinase-9. Int J Oncology 2010, 36: 1113-1120.
58. Lu CC, Yang JS, Huang AC, Hsia TC, Chou ST, et al. (2010) Chrysophanol induces necrosis through the production of ROS and alteration of ATP levels in J5 human liver cancer cells. Mol Nutr Food Res 54(7): 967-976.
59. Lee MS, Sohn CB (2008) Anti-diabetic properties of chrysophanol and its glucoside from rhubarb rhizome. Biol Pharm Bull 31(11): 2154-2157.
60. Kim SJ, Kim MC, Lee BJ, Park DH, Hong SH, et al. (2010) Anti-Inflammatory activity of chrysophanol through the suppression of NF-kB/caspase-1 activation in vitro and in vivo. Molecules 15: 6436-6451.
61. Coopoosamy RM, Magwa ML (2006) Antibacterial activity of aloe emodin and aloin A isolated from Aloe excelsa. Afr J Biotech 5(11): 1092-1094. (Pubitemid 43880254)
62. García-Sosa K, Villarreal-Alvarez N, Lübben P, Peña-Rodríguez LM (2006) Chrysophanol, an antimicrobial anthraquinone from the root extract of Colubrina greggii. J Mex Chem Soc 50(2): 76-78.
63. Seo EJ, Ngoc TM, Lee SM, Kim YS, Jung YS (2012) Chrysophanol-8-O- glucoside, an anthraquinone derivative in rhubarb, has antiplatelet and anticoagulant activities. J Pharmacol Sci 118: 245-254.
64. Basu S, Ghosh A, Hazra B (2005) Evaluation of the antibacterial activity of Ventilago madraspatana Gaertn., Rubia cordifolia Linn. and Lantana camara Linn.: isolation of emodin and physcion as active antibacterial agents. Phytother Res 19: 888-894. (Pubitemid 41665959)
65. Davis BD (1951) Aromatic biosynthesis. I. The role of shikimic acid. J Biol Chem 191: 315-325.
66. Blanco B, Prado V, Lence E, Otero JM, Garcia-Doval C, et al. (2013) Mycobacterium tuberculosis shikimate kinase inhibitors: design and simulation studies of the catalytic turnover. J Am Chem Soc 135(33): 12366-12376.
67. Dagne E, Steglich W (1984) Knipholone: a unique antraquinone derivative from Kniphofia foliosa. Phytochemistry 23: 1729-1731.
68. Bringmann G, Menche D, Bezabih M, Abegaz BM, Kaminsky R (1999) Antiplasmodial activity of knipholone and related natural phenylanthraquinones. Planta Med 65: 757-758.
69. Ngameni B, Watchueng J, Boyom FF, Keumedjio F, Ngadjui BT, et al. (2007) Antimalarial prenylated chalcones from the twigs of Dorstenia barteri var. subtriangularis. Arkivoc xiii: 116-123
70. Daniel R, Marusich E, Argyris E, Zhao RY, Skalka AM, et al. (2005) Caffeine inhibits human immunodeficiency virus type 1 transduction of nondividing cells. J Virol 79(4): 2058-2065. (Pubitemid 40204563)
71. Habtemariam S (2010) Knipholone anthrone from Kniphofia foliosa induces a rapid onset of necrotic cell death in cancer cells. Fitoterapia 81: 1013-1019.
72. Banzouzi JT, Prado R, Menan H, Valentin A, Roumestan C, Mallie M, et al. (2002) Studies on medicinal plants of Ivory coast: Investigation of an active constituent. J Ethnopharmacol 81(3): 399-341.
73. Lino CS, Taveira ML, Viana GSB, Matos FJA (1997) Analgesic and antiinflammatory activities of Justicia pectoralis Jacq and its main constituents: coumarin and umbelliferone. Phytother Res 11: 211-215. (Pubitemid 27193218)
74. Ramesh B, Pugalendi KV (2006) Antihyperglycemic effect of umbelliferone in streptozotocin-diabetic rats. J Med Food 9(4): 562-566. (Pubitemid 46095367)
75. Ramesh B, Pugalendi KV (2006) Antioxidant role of umbelliferone in STZ-diabetic rats. Life Sciences 79(3): 306-310. (Pubitemid 43782543)
76. Singh R, Singh B, Singh S, Kumar N, Kumar S, et al. (2010) Umbelliferone - An antioxidant isolated from Acacia nilotica (L.) Willd. Ex. Del. Food Chemistry 120(3): 825-830.
77. Fan GJ, Mar W, Park MK, Choi EW, Kim K, et al. (2001) A novel class of inhibitors for steroid 5α-Reductase: synthesis and evaluation of umbelliferone derivatives. Bioorg Med Chem Lett 11(7): 2361-2363. (Pubitemid 32781699)
78. Yang J, Xiao YL, He XR, Qiu GF, Hu XM (2010) Aesculetin-induced apoptosis through a ROS-mediated mitochondrial dysfunction pathway in human cervical cancer cells. J Asian Nat Prod Res 12(3): 185-193.
79. Jurd L, Corse J, King Jr AD, Bayne H, Mihara K (1971) Antimicrobial properties of 6,7-dihydroxy-,7,8-dihydroxy-,6-hydroxy- and 8-hydroxycoumarins. Phytochemistry 10(2): 2971-2974.
80. Silván AM, Abad MJ, Bermejo P, Sollhuber M, Villar A (1996) Antiinflammatory activity of coumarins from Santolina oblongifolia. J Nat Prod 59(12): 1183-1185. (Pubitemid 27026586)
81. Morales A, Condra M, Owen JA, Surridge DH, Fenemore J, et al. (1987) Is yohimbine effective in the treatment of organic impotence? Results of a controlled trial. J Urol 137(6): 1168-1172. (Pubitemid 17079048)
82. Susset JG, Tessier CD, Wincze J, Bansal S, Malhotra C, Schwacha MG (1989) Effect of yohimbine hydrochloride on erectile impotence: a double-blind study. J Urol 141(6): 1360-1363. (Pubitemid 19151796)
83. Starke K, Borowski E, Endo T (1975) Preferential blockade of presynaptic aadrenoceptors by yohimbine. Eur J Pharmacol 34(2): 385-388.
84. Bisogno T, Hanuš L, De Petrocellis L, Tchilibon S, Ponde DE, Brandi I, et al. (2001) Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Brit J Pharmacol 134: 845-852. (Pubitemid 33016156)
85. 9-tetrahydrocannabinol are neuroprotective antioxidants. Proc Natl Acad Sci USA 95: 8268-8273.
86. Malfait AM, Gallily R, Sumariwalla PF, Malik AS, Andreakos E, et al. (2000) The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc Natl Acad Sci USA 97: 9561-9566. (Pubitemid 30650815)
87. Zuardi AW, Crippa JAS, Hallak JEC, Moreira FA, Guimarães FS (2006) Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug. Braz J Med Biol Res 39: 421-429.
88. Jin J, Zhang J, Guo N, Feng H, Li L, et al. (2011) The plant alkaloid piperine as a potential inhibitor of ethidium bromide efflux in Mycobacterium smegmatis. JMed Microbiol 60: 223-229.
89. Sharma S, Kumar M, Sharma S, Nargotra A, Koul S, Khan IA (2010) Piperine as an inhibitor of Rv1258c, a putative multidrug efflux pump of Mycobacterium tuberculosis. J Antimicrob Chemother 65, 1694-1701.
90. Volak LP, Ghirmai S, Cashman JR, Court MH (2008) Curcuminoids inhibit multiple human cytochromes P450, UDP-glucuronosyltransferase, and sulfotransferase enzymes, whereas piperine is a relatively selective CYP3A4 inhibitor. Drug Metab Dispos 36(8): 1594-1605.
91. Sunila ES, Kuttan G (2004) Immunomodulatory and antitumor activity of Piper longum Linn. and piperine. J Ethnopharmacol 90: 339-346. (Pubitemid 38180485)
92. Bhardwaj RK, Glaeser H, Becquemont L, Klotz U, Gupta SK, et al. (2002) Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. J Pharmacol Exp Ther 302: 645-650. (Pubitemid 34787231)
93. Bang JS, Oh DH, Choi HM, Sur BJ, Lim SJ, et al. (2009) Anti-inflammatory and antiarthritic effects of piperine in human interleukin 1β-stimulated fibroblast-like synoviocytes and in rat arthritis models. Arthritis Res Ther 11: R49.
94. Mujumdar M, Dhuley JN, Deshmukh VK, Raman PH, Naik SR (1990) Anti-inflammatory activity of piperine. Jpn J Med Sci Biol 43(3): 95-100. (Pubitemid 20346986)
95. Kakarala M, Brenner DE, Khorkaya H, Cheng C, Tazi K, et al. (2010) Targeting breast stem cells with the cancer preventive compounds curcumin and piperine. Breast Cancer Res. Treat 122(3): 777-785.
96. Zofou D, Tene M, Tane P, Titanji VPK (2012) Antimalarial drug interactions of compounds isolated from Kigelia africana (Bignoniaceae) and their synergism with artemether, against the multidrug-resistant W2mef Plasmodium falciparum strain. Parasitol Res 110: 539-544.
97. Lai YL, Yamaguchi M (2006) Phytocomponent p-hydroxycinnamic acid stimulates bone formation and inhibits bone resorption in rat femoral tissues in vitro. Mol Cell Biochem 292: 45-52. (Pubitemid 44697398)
98. Camarero S, Cañas AI, Nousiainen P, Record E, Lomascolo A, et al. (2008) P-hydroxycinnamic acids as natural mediators for laccase oxidation of recalcitrant compounds. Environ Sci Technol 42 (17): 6703-6709.
99. Ham A, Kim DW, Kim KH, Lee SJ, Oh KB, et al. (2013) Reynosin protects against neuronal toxicity in dopamine-induced SH-SY5Y cells and 6-hydro-xydopamine-lesioned rats as models of Parkinson's disease: Reciprocal upregulation of E6-AP and down-regulation of a-synuclein. Brain Res 1524: 54-61.